| Literature DB >> 25258475 |
Tim Klüter1, Stefanie Fitschen-Oestern1, Sebastian Lippross1, Matthias Weuster1, Rolf Mentlein2, Nadine Steubesand1, Claudia Neunaber3, Frank Hildebrand4, Thomas Pufe5, Mersedeh Tohidnezhad5, Andreas Beyer6, Andreas Seekamp1, Deike Varoga1.
Abstract
The antimicrobial peptide lysozyme is an important factor of innate immunity and exerts high potential of antibacterial activity. In the present study we evaluated the lysozyme expression in serum of multiple injured patients and subsequently analyzed their possible sources and signaling pathways. Expression of lysozyme was examined in blood samples of multiple trauma patients from the day of trauma until 14 days after trauma by ELISA. To investigate major sources of lysozyme, its expression and regulation in serum samples, different blood cells, and tissue samples were analysed by ELISA and real-time PCR. Neutrophils and hepatocytes were stimulated with cytokines and supernatant of Staphylococcus aureus. The present study demonstrates the induction and release of lysozyme in serum of multiple injured patients. The highest lysozyme expression of all tested cells and tissues was detected in neutrophils. Stimulation with trauma-related factors such as interleukin-6 and S. aureus induced lysozyme expression. Liver tissue samples of patients without trauma show little lysozyme expression compared to neutrophils. After stimulation with bacterial fragments, lysozyme expression of hepatocytes is upregulated significantly. Toll-like receptor 2, a classic receptor of Gram-positive bacterial protein, was detected as a possible target for lysozyme induction.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25258475 PMCID: PMC4167455 DOI: 10.1155/2014/303106
Source DB: PubMed Journal: Mediators Inflamm ISSN: 0962-9351 Impact factor: 4.711
Figure 1Elevated lysozyme levels in serum of multiply injured patients. Time course of serum concentration of lysozyme over a period of 14 days detected by ELISA. Significant elevated concentration of lysozyme can be shown between 4 and 7 days after trauma as compared to healthy controls; ***P < 0.001, **P < 0.01, and *P < 0.5.
Figure 2Induction of lysozyme expression in leucocytes of multiply injured patients. Gene expression analysis using real-time PCR in leukocytes of multiply injured patient indicates on day 7 significant higher lysozyme levels as compared to healthy controls; *P < 0.01.
Figure 3Lysozyme expression in PMN and monocytes. (a) Polymorphonuclear cells (PMN) and monocytes were isolated from whole blood of healthy donors and lysed cells were detected for lysozyme concentration by ELISA. PMN contain higher levels compared to monocytes. (b) PMN were incubated with 50 ng/ml IL-6 and SA (supernatant 1 : 100); *P < 0.01.
Figure 4Source of lysozyme in different tissues. Lysozyme levels in tissue of healthy donors were analyzed by ELISA. Highest lysozyme concentration was detected in neutrophils, whereas liver and epidermis showed nearly similar expressions.
Figure 5Induction of lysozyme in hepatocytes. (a) HepG2 cells were incubated with IL-6 and S. aureus for 24 hours. Significant increase of lysozyme concentration was detected by ELISA after stimulation with S. aureus. (b) To evaluate transcriptional induction of lysozyme, cultivated hepatocytes (HepG2) were stimulated with IL-6 and S. aureus. Gene expression of lysozyme was measured by real-time PCR after stimulation; *P < 0.01.
Figure 6TLR2, a pathway for lysozyme induction. The induction of lysozyme in HepG2 cells was measured by ELISA after blocking TLR2 without stimulation, after stimulation with S. aureus, and after stimulation with S. aureus and additional blocking of TLR2. Stimulation with S. aureus and stimulation with S. aureus after blocking of TLR2 showed significant increase.